Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma

Accumulation of malignant plasma cells in the bone marrow causes lytic bone lesions in 80% of multiple myeloma patients. Frequently fracturing, they are challenging to treat surgically. Myeloma cells surviving treatment in the presumably protective environment of bone lesions impede their healing by...

Full description

Saved in:
Bibliographic Details
Main Authors: Hose, Dirk (Author) , Ray, Seemun (Author) , Rößler, Sina (Author) , Thormann, Ulrich (Author) , Schnettler, Reinhard (Author) , De Veirman, Kim (Author) , Khassawna, Thaqif el- (Author) , Heiss, Christian (Author) , Hild, Anne (Author) , Zahner, Daniel (Author) , Alagboso, Francisca (Author) , Henss, Anja (Author) , Beck, Susanne (Author) , Emde-Rajaratnam, Martina (Author) , Burhenne, Jürgen (Author) , Bamberger, Juliane (Author) , Menu, Eline (Author) , de Bruyne, Elke (Author) , Gelinsky, Michael (Author) , Kampschulte, Marian (Author) , Rohnke, Marcus (Author) , Wenisch, Sabine (Author) , Vanderkerken, Karin (Author) , Hanke, Thomas (Author) , Seckinger, Anja (Author) , Alt, Volker (Author)
Format: Article (Journal)
Language:English
Published: 18 December 2024
In: Journal of hematology & oncology
Year: 2024, Volume: 17, Pages: 1-20
ISSN:1756-8722
DOI:10.1186/s13045-024-01636-4
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/s13045-024-01636-4
Verlag, kostenfrei, Volltext: https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01636-4
Get full text
Author Notes:Dirk Hose, Seemun Ray, Sina Rößler, Ulrich Thormann, Reinhard Schnettler, Kim de Veirman, Thaqif El Khassawna, Christian Heiss, Anne Hild, Daniel Zahner, Francisca Alagboso, Anja Henss, Susanne Beck, Martina Emde-Rajaratnam, Jürgen Burhenne, Juliane Bamberger, Eline Menu, Elke de Bruyne, Michael Gelinsky, Marian Kampschulte, Marcus Rohnke, Sabine Wenisch, Karin Vanderkerken, Thomas Hanke, Anja Seckinger and Volker Alt
Description
Summary:Accumulation of malignant plasma cells in the bone marrow causes lytic bone lesions in 80% of multiple myeloma patients. Frequently fracturing, they are challenging to treat surgically. Myeloma cells surviving treatment in the presumably protective environment of bone lesions impede their healing by continued impact on bone turnover and can explain regular progression of patients without detectable minimal residual disease (MRD). Locally applicable biomaterials could stabilize and foster healing of bone defects, simultaneously delivering anti-cancer compounds at systemically intolerable concentrations, overcoming drug resistance.
Item Description:Gesehen am 20.03.2025
Physical Description:Online Resource
ISSN:1756-8722
DOI:10.1186/s13045-024-01636-4